[Plasmapheresis in neurology -- personal experience].
Since the time of its first therapeutic application in 1956 plasmapheresis has been accepted in neurology in the treatment of life-threatening conditions in autoimmune diseases. The own experience has based on 30 cases treated by this method: 15 cases of Guillain-Barré syndrome, 9 of myasthenia, 3 cases of polyneuropathies of unknown origin, 1 case of dermatomyositis, 1--Fischer syndrome, 1--multiple sclerosis. Twelve patients were in very serious condition with rapidly progressing deterioration. Plasmapheresis was carried out in the acute stage of the disease, possibly early. During one procedure 100-150% of plasma volume was exchanged. The therapeutic course comprised 4-5 procedures. The result was very good in 10 cases, and good in 16. In 3 cases no effect was obtained (Guillain-Barré syndrome and polyneuropathy) and one patient died (carcinomatous polyneuropathy). Plasmapheresis is the method of choice in serious neurological states in Guillain-Barré syndrome and myasthenia.
Załeska
B
B
Kliniki Neurologicznej Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej, Warszawie.
Domzał
T
T
Korsak
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy; D009157:Myasthenia Gravis / Q000628:therapy; D010956:Plasmapheresis / Q000379:methods*; D011129:Polyradiculoneuropathy / Q000628:therapy*; D016896:Treatment Outcome
Plazmafereza w neurologii--doświadczenia własne.